Diversity of metabolic syndrome criteria in association with cardiovascular diseases - A family medicine-based investigation

Medical Science Monitor

Volumn 19, Issue 1, 2013, Pages 571-578

  Ivezić Lalić, Dragica ^a   Marković, Biserka Bergman ^b   Kranjčević, Ksenija ^b   Ker, Josipa ^b   Vrdoljak, Davorka ^c   Vučak, Jasna ^a  

^a GP's Office   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c UNIVERSITY OF SPLIT   (Croatia)

Author keywords

Cardiovascular diseases; Family practice; Metabolic syndrome X

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FAMILY MEDICINE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTICENTER STUDY; PHYSICAL ACTIVITY; PREVALENCE; PROSPECTIVE STUDY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; AGE FACTORS; CARDIOVASCULAR DISEASES; CROATIA; CROSS-SECTIONAL STUDIES; DEMOGRAPHY; DIET, MEDITERRANEAN; FEMALE; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SMOKING;

EID: 84880407715     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.889343     Document Type: Article

References (31)

1. Reaven GM: Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37(12): 1595-607
2. Kaplan NM: The deadly quartet and the insulin resistance syndrome: an historical overview. Hypertens Res, 1996; 19(Suppl.1): S9-11
3. Kahn R, Buse J, Ferrannini E, Stern M; American Diabetes Association; European Association for the Study of Diabetes: The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care, 2005; 28(9): 2289-304
4. Rydén L, Standl E, Bartnik M et al: Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J, 2007; 28(1): 88-136
5. Hanefeld M, Köhler C: The metabolic syndrome and its epidemiologic dimensions in historical perspective. Z Arztl Fortbild Qualitatssich, 2002; 96(3): 183-88
6. Grundy SM, Brewer HB Jr, Cleeman JI et al: Definition of the metabolic syndrome: Report of NHLBI/AHA conference on scientific issues related to definition. Circulation, 2004; 109(3): 433-38
7. de Simone G, Devereux RB, Chinali M et al: Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study. Diabetes Care, 2007; 30(7): 1851-56
8. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation, 2002; 106(25): 3143-421
9. World Health Organisation: Definition, diagnosis and clasification of diabetes mellitus and its complications: report of A WHO consultatio. Part 1: dignosis and clasification of diabetes mellitus. Available at. URL: http://whqlibdoc.who.int/hq/1999/who_ncd_ncs_99.2.pdf. Accessed Apr 03, 2013
10. The IDF consensus worldwide definition of the metabolic syndrome. International Diabetes Federation, 2006. Available at. URL: http://www.idf.org/webdata/docs/IDF_Meta_def_final.pdf. Accessed Apr 03, 2013
11. Einhorn D, Reaven GM, Cobin RH et al: American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract, 2003; 9(3): 237-52
12. Balkau B, Charles MA: Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med, 1999; 16(5): 442-43
13. Bergman Marković B, Kern J, Blažeković-Milaković S et al: Metabolički sindrom u obiteljskoj medicini. Acta Med Croatica, 2007; 61: 245-51
14. Bergman Marković B, Vrdoljak D, Kranjčević K et al: Continental-Mediterranean and rural-urban differences in cardiovascular risk factors in Croatian population. Croat Med J, 2011; 52(4): 566-75
15. Vrdoljak D, Bergman Marković B, Kranjčević K et al: How well do anthropometric indices correlate with cardiovascular risk factors? A cross-sectional study in Croatia. Med Sci Monit, 2012; 18(2): PH6-11
16. Rumboldt M, Rumboldt Z, Pesenti S: Association between the metabolic syndrome and parental history of premature cardiovascular disease. Eur Heart J, 2006; 27(20): 2481
17. Kolcić I, Vorko-Jović A, Salzer B et al: Metabolic syndrome in a metapopu lation of Croatian island isolates. Croat Med J, 2006; 47(4): 585-92
18. Vuletić S, Kern J, Ivanković D et al: Metabolički sindrom u populaciji Hrvatskekardiovaskularna multirizičnost. Acta Med Croatica, 2007; 61(3): 239-43 [in Croatian]
19. Graham I, Atar D, Borch-Johnsen K et al: European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). Eur Heart J, 2007; 28(19): 2375-414
20. WHO: Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser, 1995; 854: 1-452
21. Nilsson PM, Engström G, Hedblad B: The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects-a population-based study comparing three different definitions. Diabet Med, 2007; 24(5): 464-72
22. Athyros VG, Ganotakis ES, Elisaf MS et al: Prevalence of vascular disease in metabolic syndrome using three proposed definitions. Int J Cardiol, 2007; 117(2): 204-10
23. Moebus S, Balijepalli C, Lösch C et al: Age-and sex-specific prevalence and ten-year risk for cardiovascular disease of all 16 risk factor combinations of the metabolic syndrome-A cross-sectional study. Cardiovasc Diabetol, 2010; 9: 34
24. Lawlor DA, Smith GD, Ebrahim S: Does the new International Diabetes Federation definition of the metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British Women's Heart and Health Study. Diabetologia, 2006; 49(1): 41-48
25. Hadaegh F, Mohebi R, Cheraghi L et al: Do different metabolic syndrome definitions predict cerebrovascular events and coronary heart disease independent of their components?: 9 years follow-up of the tehran lipid and glucose study. Stroke, 2012; 43(6): 1669-71
26. Lafortuna CL, Agosti F, De Col A et al: Prevalence of the metabolic syndrome and its components among obese men and women in Italy. Obes Facts, 2012; 5(1): 127-37
27. Forti P, Pirazzoli GL, Maltoni B et al: Metabolic syndrome and all-cause mortality in older men and women. Eur J Clin Invest, 2012; 42(9): 1000-9
28. Moebus S, Hanisch JU, Aidelsburger P et al: Impact of 4 different definitions used for the assessment of the prevalence of the Metabolic Syndrome in primary healthcare: The German Metabolic and Cardiovascular Risk Project (GEMCAS). Cardiovasc Diabetol, 2007; 6: 22
29. Fiuza M, Cortez-Dias N, Martins S, Belo A; VALSIM study investigators: Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk-results from the VALSIM Study. Rev Port Cardiol, 2008; 27(12): 1495-529
30. Deka R, Durakovic Z, Niu W et al: Prevalence of metabolic syndrome and related metabolic traits in an island population of the Adriatic. Ann Hum Biol, 2012; 39(1): 46-53
31. Tucak-Zorić S, Curcić IB, Mihalj H et al: Prevalence of metabolic syndrome in the interior of Croatia: the Baranja region. Coll Antropol, 2008; 32(3): 659-65